Actively Recruiting
Prospective Multicenter Clinical and Biological Database in Colon Cancer and Related Tumors
Led by Institut du Cancer de Montpellier - Val d'Aurelle · Updated on 2025-02-12
600
Participants Needed
2
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Colorectal cancer is a major health concern, being the second leading cause of cancer-related death in France with 37,000 new cases and 17,000 deaths annually. This research aims to better understand how colon cancer and related tumors grow and spread, focusing on the tumor invasion and metastatic processes. By studying these processes, researchers hope to discover new biomarkers and develop new treatments. Participants in this study will have blood and tissue samples collected before or after surgery, including frozen and paraffin-embedded tissue sections. Clinical data about each patient will also be recorded in a standardized database. This biological collection supports research into both early and advanced stages of colon cancer and related tumors. During the study, researchers will track both clinical and biological risk factors for colorectal cancer over the course of six years. Participants will undergo sample collection and data recording, contributing to a large database that may help identify key factors in tumor behavior. The study is conducted by the Institut du Cancer de Montpellier - Val d'Aurelle and lasts until December 2030.
CONDITIONS
Brief Title
Clinical and Biological Database in Colon Cancer and Colic Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient undergoing colon cancer surgery (stage I, II, III and IV)
- Patient operated for liver, lung, or peritoneal metastases from colon cancer
- Patient operated for pre-neoplastic lesion such as adenomatous or villous adenoma polyp
- Patient with familial polyposis eligible for colectomy
- Age 18 years or older
- Signed informed consent
You will not qualify if you...
- Patient not affiliated to Social Protection system
- Patient unable to understand or comply with study instructions or requirements for psychological, family, social, or geographical reasons
- Patient under guardianship
- Minor patient
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Variable based on individual surgery and recovery
Participants undergo colon cancer surgery or surgery for related tumors with collection of blood and tissue samples before or after surgery.
1 surgical visit with biological sample collection
Duration - Up to 6 years until study completion
Participants have standardized clinical data collected and biological samples stored as part of ongoing follow-up.
Visit schedule varies based on clinical care; biological samples collected as available
Trial Site Locations
Total: 2 locations
1
CHRU de Montpellier
Montpellier, Hérault, France, 34298
Actively Recruiting
2
Institut Régional du cancer de Montpellier
Montpellier, France, 34298
Actively Recruiting
Research Team
A
Aurore MOUSSION
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here